A global health action agenda for the Biden administration by Gostin, Lawrence O. et al.
Georgetown University Law Center 
Scholarship @ GEORGETOWN LAW 
2020 
A global health action agenda for the Biden administration 
Lawrence O. Gostin 
Georgetown University - Law Center - O'Neill Institute for National and Global Health Law, 
gostin@law.georgetown.edu 
Donna E. Shalala 
Member of the U.S. House of Representatives 
Margaret A. Hamburg 
National Academy of Medicine 
Barry R. Bloom 
Harvard T.H. Chan School of Public Health, Harvard University 
Jeffrey P. Koplan 
Emory Global Health Institute, Emory University 
See next page for additional authors 
 
 




The Lancet, Online First, Dec. 1, 2020, at 1-3. 
This open-access article is brought to you by the Georgetown Law Library. Posted with permission of the author. 
Follow this and additional works at: https://scholarship.law.georgetown.edu/facpub 
 Part of the Health Law and Policy Commons, and the Human Rights Law Commons 
Authors 
Lawrence O. Gostin, Donna E. Shalala, Margaret A. Hamburg, Barry R. Bloom, Jeffrey P. Koplan, Barbara K. 
Rimer, and Michelle A. Williams 
This article is available at Scholarship @ GEORGETOWN LAW: https://scholarship.law.georgetown.edu/facpub/2335 
Comment
www.thelancet.com   Published online December 1, 2020   https://doi.org/10.1016/S0140-6736(20)32585-X 1
A global health action agenda for the Biden administration
Joe Biden will assume the US presidency at a time of 
unprecedented global health crises, with the COVID-19 
pandemic and major setbacks in reducing poverty, 
hunger, and disease. The COVID-19 pandemic offers rare 
opportunities for the US President-elect to spearhead 
long-overdue structural changes and revitalise global 
health leadership. Building trust among global partners 
will be challenging, given the USA’s withdrawal from, 
and disruption of, international cooperation under the 
presidency of Donald Trump. The USA will have to lead 
in a different, more collaborative way.
The COVID-19 pandemic is currently the world’s 
greatest challenge. The incoming administration should 
mobilise partners to fund the UN COVID-19 Global 
Humanitarian Response Plan (GHRP), designed to 
coordinate health and economic action in vulnerable 
countries. So far, the UN has received only 40% of the 
US$9·5 billion GHRP goal for 2020.1 To gain high-level 
political support, the Biden administration will need to 
press for a UN Security Council resolution on COVID-19, 
modelled on the 2014 resolution on Ebola virus disease 
as a threat to peace and security.
Biden must also strengthen WHO, not only for the 
response to COVID-19, but also for the full gamut 
of health challenges, ranging from maternal, child, 
and adolescent health to injuries, non-communicable 
diseases, and universal health coverage. Addressing 
health inequities will be crucial in all these domains. 
WHO’s $5·8 billion biennial budget—about the size of 
a large US hospital—is incommensurate with its global 
mandate. WHO, moreover, controls less than a quarter 
of that inadequate budget, with most funds already 
earmarked. The Biden administration should coordinate 
with other member states to submit a World Health 
Assembly resolution doubling mandatory contributions 
to WHO.
Placing WHO in the vortex of geopolitical tensions, 
as has occurred during the COVID-19 pandemic, is 
destructive and the USA must not cause or add to 
the politicisation of WHO. Member states, including 
the USA, should pledge to maintain the scientific 
integrity and political neutrality of WHO. The 
Biden administration can press for necessary WHO 
reforms, including more inclusive governance and civil 
society participation. 
COVID-19 has revealed major weaknesses in the 
International Health Regulations (IHR) 2005. The in-
coming US administration should support IHR reforms. 
In our view, the IHR must protect the confidentiality 
of unofficial data sources while making credible data 
public. The IHR should also empower the WHO Director-
General to declare an intermediate level for public 
health emergencies of international concern. Impor-
tantly, we believe the IHR should more clearly define 
states’ international assistance responsibilities to build 
core health-system capacities.2 
Another urgent issue for the incoming administration 
will be to help provide equitable worldwide distri-
bution of COVID-19 vaccines. The USA should join 
the 189 countries participating in the COVID-19 Vaccine 
Global Access (COVAX) Facility.3 COVAX aims to ensure 
that 92 low-income and middle-income countries 
equitably access COVID-19 vaccines.4 The USA, working 
with partners, should fund the $5 billion COVAX Advance 
Market Commitments5 to incentivise mass scale-up of 
vaccine production and procure vaccine doses,6 along 
with providing additional funds for distribution.
Vaccine nationalism is a major challenge. Even before 
the full regulatory approval of any COVID-19 vaccine 
candidates, confirmed purchases by individual countries 
cover 6·8 billion doses, with another 2·8 bil lion doses 
under negotiation or reserved. Low-income countries hold 
no prepurchase agreements,7 and are reliant on COVAX. 
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COVAX has signed agreements for only 700 million 
doses of COVID-19 vaccines7 of a targeted 2 billion doses 
by 2021.8 President-elect Biden will need to launch 
international negotiations to redistribute a substantial 
portion of national COVID-19 vaccine purchases to 
COVAX, while also supporting immunisation education 
campaigns to increase coverage.
Beyond the pandemic itself, COVID-19 has unleashed 
vast economic, social, and health crises. Disruptions 
to health services because of COVID-19 might lead 
to an estimated extra 1·5 million AIDS, tuberculosis, 
and malaria deaths in 2020 alone.9 Child vaccination 
campaigns have stalled, even as measles deaths increased 
by 50% from 2016 to 2019.10 The polio eradication 
campaign has also been disrupted. Maternal and child 
deaths are projected to rise sharply.11 The World Food 
Programme (WFP) projects a doubling of children and 
adults facing acute hunger globally by the end of 2020.12
The US Congress should dedicate 2% of COVID-19 
emergency relief spending to global humanitarian assis-
tance.13 With lower-income countries facing crushing 
debt service burdens, the incoming US administration 
should support the extension of a multiyear debt service 
moratorium for these countries. Going further, debt 
cancellation would increase funds needed to mitigate 
COVID-19’s long-term health and socioeconomic effects.
With compound health crises worldwide, UN human-
i tarian appeals face record shortfalls. The Biden admin-
istration could build on the tradition of US humani tarian 
leadership by funding at least 40%—the USA’s share of 
high-income country gross national income14—of UN and 
WFP appeals.
The USA has developed innovative global health 
policies, which have languished under President Trump. 
The incoming administration should restore US Centers 
for Disease Control and Prevention (CDC) funding for 
surveillance, data analysis, and health worker training 
in lower-income countries. CDC’s China office, for 
example, was cut from 47 to 14 staff under the Trump 
presidency.15 Overall, US relationships are frayed, not 
only with China but also other key allies.
The US Congress should also fund and re-energise the 
global health security agenda, designed to strengthen 
and evaluate national health-system capacities globally. 
Rectifying President Trump’s damaging decisions, 
we urge the Biden administration to re-establish the 
White House National Security Council Directorate for 
Global Health Security and Biodefense and relaunch 
the PREDICT virus identification and tracking project. 
The incoming administration should also fully replenish 
the US Strategic National Stockpile of medical supplies to 
prepare for the next health emergency.
The COVID-19 pandemic has underscored the impor-
tance of therapeutic countermeasures. To accelerate 
access to scientific advances, the incoming administration 
will need to increase domestic research and development 
funding by at least $1 billion annually, as the National 
Academy of Medicine has recommended.16 Globally, the 
USA could offer increased support to the Coalition for 
Epidemic Preparedness Innovations (CEPI), which funds 
platform technologies to rapidly respond to high priority 
infectious disease threats. Furthermore, President-elect 
Biden should break with previous administrations by 
encouraging liberal use of Trade-Related Aspects of 
Intellectual Property Rights (TRIPS) flexibilities and avoid 
TRIPS-plus trade agreements, which make essential 
medicines unaffordable.17
Beyond COVID-19, the world faces life-threatening 
challenges, with antimicrobial resistance and the climate 
crisis, among the most urgent. Antimicrobial resistance 
threatens our ability to treat common infections. The 
Biden admin istration should enhance stewardship of 
antimicrobials, regulating agricultural and medical use, 
while incen tivising pharmaceutical and biotech companies 
to develop new antimicrobials and supporting multilateral 
efforts to confront antimicrobial resistance.
Climate change adversely affects social and environ-
mental determinants of health, including clean air, safe 
drinking water, food, and secure shelter.18 President-
elect Biden plans to rejoin the Paris Agreement on 
climate change,19 working with partners to regulate 
greenhouse gas emissions, while creating economic 
incentives for green technologies. Environmental 
steward ship and advancing planetary health should be 
priorities for the incoming administration. 
Our proposed Biden action agenda is undoubtedly 
ambitious, but will reap huge benefits. COVID-19 has 
shown that US interests are inextricably tied to global 
health security. New disease outbreaks anywhere pose 
threats everywhere. Healthier and safer populations 
are more stable and economically productive. This 
is the time to revitalise US global health leadership, 
after a ruinous retreat from global solidarity under 
the Trump admin istration. International cooperation 
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on the compound crises of COVID-19 could become a 
model for tackling other existential global hazards. Out 
of a crisis comes opportunities to build a safer, healthier, 
and more just world.
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